Exploring the synergistic effects of Life's Essential 8, insulin resistance, and CRP on cardiometabolic

Jiang Liu1, Chuang Yang2, Wenke Cheng2

  • 1Department of Cardiology, Yingtan People's Hospital, Yingtan, Jiangxi Province, China.

PubMed

Insights

Maintaining high cardiovascular health, measured by Life's Essential 8 (LE8), significantly lowers the risk of developing cardiometabolic multimorbidity (CMM). This protective effect is partly due to reduced insulin resistance and inflammation.

Area of Science:

  • Cardiology
  • Public Health
  • Metabolic Disease Research

Background:

  • Cardiometabolic multimorbidity (CMM) is the co-occurrence of diseases like coronary artery disease, stroke, and type 2 diabetes.
  • Life's Essential 8 (LE8) is a metric for cardiovascular health (CVH) that includes behavioral and metabolic factors.
  • The relationship between LE8 and CMM risk has not been previously explored.

Purpose of the Study:

  • To investigate the independent and combined effects of LE8, insulin resistance (IR), and C-reactive protein (CRP) on CMM risk.
  • To determine the extent to which IR and CRP mediate the association between LE8 and CMM.

Main Methods:

  • A prospective cohort study of 304,568 UK Biobank participants without baseline CMM.
  • Cox proportional hazards models and restricted cubic splines assessed LE8 and CMM risk.
  • Mediation analyses identified the roles of triglyceride-glucose index (TyG) and CRP.

Main Results:

  • Higher LE8 scores were linked to a significantly reduced risk of CMM (HR per 10-point increase: 0.65).
  • Increased LE8 scores delayed CMM onset by up to 47.3 months.
  • TyG and CRP mediated 18.8% and 2.9% of LE8's protective effect, respectively.

Conclusions:

  • High LE8 scores are associated with a lower risk of developing CMM.
  • Reductions in IR and inflammation partially mediate this protective effect.
  • Promoting CVH and addressing metabolic/inflammatory factors may prevent CMM.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.9K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
78
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62